These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 25486070)
1. Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers. Modugno M; Banfi P; Gasparri F; Borzilleri R; Carter P; Cornelius L; Gottardis M; Lee V; Mapelli C; Naglich JG; Tebben A; Vite G; Pastori W; Albanese C; Corti E; Ballinari D; Galvani A Exp Cell Res; 2015 Mar; 332(2):267-77. PubMed ID: 25486070 [TBL] [Abstract][Full Text] [Related]
2. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer. Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046 [TBL] [Abstract][Full Text] [Related]
3. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak. Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383 [TBL] [Abstract][Full Text] [Related]
4. Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML. Ewald L; Dittmann J; Vogler M; Fulda S Cell Death Dis; 2019 Dec; 10(12):917. PubMed ID: 31801941 [TBL] [Abstract][Full Text] [Related]
5. MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor. Xiao Y; Nimmer P; Sheppard GS; Bruncko M; Hessler P; Lu X; Roberts-Rapp L; Pappano WN; Elmore SW; Souers AJ; Leverson JD; Phillips DC Mol Cancer Ther; 2015 Aug; 14(8):1837-47. PubMed ID: 26013319 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by Ginkgo biloba (EGb761) in melanoma cells is Mcl-1-dependent. Wang Y; Lv J; Cheng Y; Du J; Chen D; Li C; Zhang J PLoS One; 2015; 10(4):e0124812. PubMed ID: 25860257 [TBL] [Abstract][Full Text] [Related]
7. DRP-1 is required for BH3 mimetic-mediated mitochondrial fragmentation and apoptosis. Milani M; Byrne DP; Greaves G; Butterworth M; Cohen GM; Eyers PA; Varadarajan S Cell Death Dis; 2017 Jan; 8(1):e2552. PubMed ID: 28079887 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition. Song T; Chai G; Liu Y; Xie M; Chen Q; Yu X; Sheng H; Zhang Z Eur J Pharm Sci; 2015 Apr; 70():64-71. PubMed ID: 25596561 [TBL] [Abstract][Full Text] [Related]
9. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800 [TBL] [Abstract][Full Text] [Related]
10. The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia. Besbes S; Pocard M; Mirshahi M; Billard C Crit Rev Oncol Hematol; 2016 Apr; 100():32-6. PubMed ID: 26899021 [TBL] [Abstract][Full Text] [Related]
11. Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737. Lucas KM; Mohana-Kumaran N; Lau D; Zhang XD; Hersey P; Huang DC; Weninger W; Haass NK; Allen JD Clin Cancer Res; 2012 Feb; 18(3):783-95. PubMed ID: 22173547 [TBL] [Abstract][Full Text] [Related]
12. Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor. Wu X; Zhang LS; Toombs J; Kuo YC; Piazza JT; Tuladhar R; Barrett Q; Fan CW; Zhang X; Walensky LD; Kool M; Cheng SY; Brekken R; Opferman JT; Green DR; Moldoveanu T; Lum L Nat Cell Biol; 2017 Oct; 19(10):1226-1236. PubMed ID: 28945232 [TBL] [Abstract][Full Text] [Related]
14. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354 [TBL] [Abstract][Full Text] [Related]
15. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa. Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285 [TBL] [Abstract][Full Text] [Related]
16. Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins. Long J; Liu L; Nikolovska-Coleska Z; Shangary S; Yi H; Wang S; Wang S BMC Biotechnol; 2013 May; 13():45. PubMed ID: 23705845 [TBL] [Abstract][Full Text] [Related]
17. Selective BH3-mimetics targeting BCL-2, BCL-XL or MCL-1 induce severe mitochondrial perturbations. Henz K; Al-Zebeeby A; Basoglu M; Fulda S; Cohen GM; Varadarajan S; Vogler M Biol Chem; 2019 Jan; 400(2):181-185. PubMed ID: 29924730 [TBL] [Abstract][Full Text] [Related]
18. BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X Greaves G; Milani M; Butterworth M; Carter RJ; Byrne DP; Eyers PA; Luo X; Cohen GM; Varadarajan S Cell Death Differ; 2019 Jun; 26(6):1037-1047. PubMed ID: 30185825 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104 [TBL] [Abstract][Full Text] [Related]
20. Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro. Guo L; Eldridge S; Furniss M; Mussio J; Davis M Toxicol Appl Pharmacol; 2018 Dec; 360():88-98. PubMed ID: 30268579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]